![Prospective registration and reporting of trial number in randomised clinical trials: global cross sectional study of the adoption of ICMJE and Declaration of Helsinki recommendations | The BMJ Prospective registration and reporting of trial number in randomised clinical trials: global cross sectional study of the adoption of ICMJE and Declaration of Helsinki recommendations | The BMJ](https://www.bmj.com/content/bmj/369/bmj.m982/F1.medium.jpg)
Prospective registration and reporting of trial number in randomised clinical trials: global cross sectional study of the adoption of ICMJE and Declaration of Helsinki recommendations | The BMJ
![Ongoing Clinical Trials for the Management of the COVID-19 Pandemic: Trends in Pharmacological Sciences Ongoing Clinical Trials for the Management of the COVID-19 Pandemic: Trends in Pharmacological Sciences](https://www.cell.com/cms/attachment/8e9a80c5-3e9a-4f55-9f5e-4d0638d176a9/gr1_lrg.jpg)
Ongoing Clinical Trials for the Management of the COVID-19 Pandemic: Trends in Pharmacological Sciences
![Make it Public – new partnership will automatically register all UK clinical trials | NHS Research Scotland | NHS Research Scotland Make it Public – new partnership will automatically register all UK clinical trials | NHS Research Scotland | NHS Research Scotland](https://www.nhsresearchscotland.org.uk/uploads/images/contentheader/1634721495_MakeItPublicgraphic.jpg)
Make it Public – new partnership will automatically register all UK clinical trials | NHS Research Scotland | NHS Research Scotland
![PDF) Prevalence of clinical trial status discrepancies: A cross-sectional study of 10,492 trials registered on both ClinicalTrials.gov and the European Union Clinical Trials Register PDF) Prevalence of clinical trial status discrepancies: A cross-sectional study of 10,492 trials registered on both ClinicalTrials.gov and the European Union Clinical Trials Register](https://i1.rgstatic.net/publication/323620686_Prevalence_of_clinical_trial_status_discrepancies_A_cross-sectional_study_of_10492_trials_registered_on_both_ClinicalTrialsgov_and_the_European_Union_Clinical_Trials_Register/links/5aa0955ea6fdcc22e2cf4635/largepreview.png)
PDF) Prevalence of clinical trial status discrepancies: A cross-sectional study of 10,492 trials registered on both ClinicalTrials.gov and the European Union Clinical Trials Register
![Compliance with legal requirement to report clinical trial results on ClinicalTrials.gov: a cohort study - The Lancet Compliance with legal requirement to report clinical trial results on ClinicalTrials.gov: a cohort study - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/c64c0430-8a6c-429a-a3a0-4e4afdc34f46/gr1_lrg.jpg)
Compliance with legal requirement to report clinical trial results on ClinicalTrials.gov: a cohort study - The Lancet
![The WHO International Clinical Trials Registry Platform: Providing global clinical trial information to all - On Medicine The WHO International Clinical Trials Registry Platform: Providing global clinical trial information to all - On Medicine](https://blogs.biomedcentral.com/on-medicine/wp-content/uploads/sites/6/2020/05/who-map.jpg)
The WHO International Clinical Trials Registry Platform: Providing global clinical trial information to all - On Medicine
Patrick Wild Centre on Twitter: "Join us for our trial information evenings in May. An opportunity to find out more about the Zynerba pharmaceuticals clinical trial of cannabidiol gel for fragile X
![CambridgeATS on Twitter: "Next G2T webinar on 8 September, 4pm BST! Dr Tom Oakley, VP of EU Regulatory at ProPharma Group, will talk about the role of regulators in developing new medicines. CambridgeATS on Twitter: "Next G2T webinar on 8 September, 4pm BST! Dr Tom Oakley, VP of EU Regulatory at ProPharma Group, will talk about the role of regulators in developing new medicines.](https://pbs.twimg.com/media/E-R2-DiXoAImpYQ.jpg)